Search

everythinglearnresearchcommunity

for

Search:↓

Hormone therapies like birth control pills and spironolactone are safe and effective for treating women's adult acne.

Women with PCOS have higher levels of certain blood clotting factors, suggesting a greater risk of cardiovascular issues.

Minoxidil nanoparticles can potentially be a more effective treatment for hair growth than current treatments.

Micro-segmental hair analysis helps detect drug use patterns and estimate drug consumption days.

Oral ciclosporin A and topical treatments both reduce hair loss and scaling in dogs with sebaceous adenitis, but using both together is most effective.

Derma rollers show promise for skin improvement and drug delivery, but more research is needed on their safety and effectiveness.

Women with PCOS in Sicily show different levels of metabolic problems depending on their PCOS type, with obesity and abnormal lipid profiles being common.

High and low doses of prednisolone helped 62% of children with severe alopecia regrow hair with some weight gain and mild acne as side effects.

Vitamin D deficiency is common in women with PCOS and linked to some metabolic problems, but not the main cause of their metabolic issues.

Alfacalcidiol and metformin together lowered testosterone in women with PCOS, but did not significantly improve acne, hair growth, or pregnancy rates.

New method uses hair follicle cells to estimate human body clock phase, potentially improving sleep disorder diagnosis.

Overweight women with PCOS have higher levels of certain hormones that could indicate a higher risk of heart and metabolic problems.

No clear link between finasteride use and acute pancreatitis risk.

Finasteride reduces prostate cancer risk but may increase high-grade cancer chances.

A combination of nanomilled oral testosterone and dutasteride normalized testosterone levels in men with low testosterone and is safe for short-term use.

Hair loss drugs like finasteride may cause lasting sexual and mood side effects, and more research is needed to understand these risks.

Mild thyroid issues don't affect the metabolism and hormones of women with PCOS.

Maintaining skin health is crucial for overall well-being and involves protecting against environmental damage and using skincare products.

Hormone therapy may increase migraines in transgender women and decrease them in transgender men; more research is needed on migraine management in transgender individuals.

A patient had painful swollen lymph nodes after a cosmetic skin and hair treatment, suggesting doctors should warn about this risk.

Finasteride helps induce ovulation in nonresponder PCOS women.

The study found that polymorphous light eruption varies among patients and can be distinguished from benign summer light eruption by the time it takes for symptoms to appear after sun exposure.

Histopathology is not reliable for detecting early fibrosis in traction alopecia or for showing how severe it is.

Premature hair greying may indicate a higher risk of metabolic problems.

Pakis Gajah (Angiopteris evecta) water extract may promote hair growth in rabbits, but more research is needed for human use.

Platelet-Rich Plasma (PRP), a protein-rich extract from a patient's blood, shows promise in improving hair density, thickness, and quality, but the best method of use and number of treatments needed for noticeable results are still unclear.

Ethinylestradiol/chlormadinone acetate may be an effective and well-tolerated treatment for skin conditions caused by excess androgens.

Women with PCOS often experience mental health issues like depression and anxiety.

The emulgel with 11.5% oil and 1.75% gelling agent effectively delivers fluconazole topically with improved spreadability and stability.